Literature DB >> 31639040

Correction to: DNA methylation signature is prognostic of choroid plexus tumor aggressiveness.

Malgorzata Pienkowska1, Sanaa Choufani1, Andrei L Turinsky1,2, Tanya Guha1, Diana M Merino3, Ana Novokmet1, Michael Brudno1,2,4, Rosanna Weksberg1,5,6, Adam Shlien1,7, Cynthia Hawkins1,7, Eric Bouffet8,6, Uri Tabori1,8,6, Richard J Gilbertson9, Jonathan L Finlay10, Nada Jabado11, Christian Thomas12, Martin Sill13,14, David Capper15,16, Martin Hasselblatt12, David Malkin17,18,19,20.   

Abstract

After publication of the original article [1], authors have requested to add a 'J' as middle name for Richard Gilbertson. Hence, full name should be Richard J Gilbertson.

Entities:  

Year:  2019        PMID： 31639040      PMCID： PMC6802296          DOI： 10.1186/s13148-019-0737-7

Source DB:  PubMed          Journal:  Clin Epigenetics        ISSN： 1868-7075            Impact factor:   6.551


Correction to: Clin Epigenetics https://doi.org/10.1186/s13148-019-0708-z After publication of the original article [1], authors have requested to add a ‘J’ as middle name for Richard Gilbertson. Hence, full name should be Richard J Gilbertson. The original article has been corrected. The publisher apologies for the inconvenience.
  1 in total

1.  DNA methylation signature is prognostic of choroid plexus tumor aggressiveness.

Authors:  Malgorzata Pienkowska; Sanaa Choufani; Andrei L Turinsky; Tanya Guha; Diana M Merino; Ana Novokmet; Michael Brudno; Rosanna Weksberg; Adam Shlien; Cynthia Hawkins; Eric Bouffet; Uri Tabori; Richard J Gilbertson; Jonathan L Finlay; Nada Jabado; Christian Thomas; Martin Sill; David Capper; Martin Hasselblatt; David Malkin
Journal:  Clin Epigenetics       Date:  2019-08-13       Impact factor: 6.551
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.